Cover Image

Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD

To describe the adverse events associated with brolucizumab, in particular the sequence of intraocular inflammation (IOI), retinal vasculitis (RV), and/or retinal vascular occlusion (RO).

Saved in:
Bibliographic Details
Main Authors: Khoramnia, Ramin (Author) , Figueroa, Marta S. (Author) , Hattenbach, Lars-Olof (Author) , Pavésio, Carlos E. (Author) , Anderesi, Majid (Author) , Schmouder, Robert (Author) , Chen, Yu (Author) , de Smet, Marc D. (Author)
Format: Article (Journal)
Language:English
Published: 21 December 2021
In: Graefe's archive for clinical and experimental ophthalmology
Year: 2021, Volume: 260, Issue: 6, Pages: 1843-1856
ISSN:1435-702X
DOI:10.1007/s00417-021-05518-0
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00417-021-05518-0
Get full text
Author Notes:Ramin Khoramnia, Marta S. Figueroa, Lars-Olof Hattenbach, Carlos E. Pavesio, Majid Anderesi, Robert Schmouder, Yu Chen, Marc D. de Smet
Description
Summary:To describe the adverse events associated with brolucizumab, in particular the sequence of intraocular inflammation (IOI), retinal vasculitis (RV), and/or retinal vascular occlusion (RO).
Item Description:Gesehen am 27.06.2023
Physical Description:Online Resource
ISSN:1435-702X
DOI:10.1007/s00417-021-05518-0

Similar Items